pillbase.ru

PALSONIFY

Active substance: paltusotine

TABLET, FILM COATED · PALTUSOTINE HYDROCHLORIDE 20 mg/1

United StatesActive

Marketing holder: Crinetics Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Palsonify
    paltusotine hydrochloride
    EMEA/H/C/006636
    Crinetics Pharmaceuticals Europe GmbH
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12097-9bc6-7b5f-9f41-be15e835fae9,01a12097-9bcd-79da-b90e-6c4170f4c3bd;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
84015-920
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 84015-920 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 84015-920 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 84015-920 · Verified 2026-10-09 · open in source